Osteoarthritis susceptibility 2
MONDO:0007704Also known as: MATN3 osteoarthritis, osteoarthritis caused by mutation in MATN3, osteoarthritis susceptibility 2, osteoarthritis susceptibility type 2, Dipoa, Heberden nodes, OADIP, OS2
16 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
High-Tech gloves aim to ease arthritis pain – but trial stalls
Symptom relief TerminatedThis study tested whether gloves with tiny semiconductors embedded in the fabric could reduce pain and improve hand function in people with hand osteoarthritis. Sixteen participants wore either the active gloves or identical-looking placebo gloves. The trial was terminated early,…
Phase: NA • Sponsor: Altoona Center for Clinical Research • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Laser light tested for achy hands – but study stopped early
Symptom relief TerminatedThis study tested whether low level laser therapy (LLLT) could reduce pain and improve hand function in people with hand osteoarthritis. About 83 military members and their families received either real or sham laser treatment weekly for six weeks. The trial was terminated early,…
Phase: NA • Sponsor: David Moss • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC